UB Paderborn / Katalog / Suche / in CDI

P997: PROTEOMIC ANALYSIS ON PLATELETS OF ESSENTIAL THROMBOCYTHEMIA PATIENTS UNDERSCORES THE ROLE OF MITOCHONDRIA IN JAK2 V617F PLATELET REACTIVITY AND FUNCTION

HemaSphere, 2022-06, Vol.6 (Suppl), p.887-888

2022

Link zum Volltext

Verfügbarkeit prüfen

Study of toxicity of the conventional treatments in myeloproliferative neoplasms, based on the functional status of the RUNX1/CBF-BETA/P300/HIPK2 complex

Annals of oncology, 2018-09, Vol.29, p.vi32-vi32

2018

Link zum Volltext

Verfügbarkeit prüfen

When should preemptive antiviral therapy for active CMV infection be withdrawn from allogeneic stem cell transplant recipientsquest

Bone marrow transplantation (Basingstoke), 2017-10, Vol.52 (10), p.1448

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment Of Essential Thrombocythemia In Europe: Observational Study Of 3649 Patients Of High Risk (Exels)

Haematologica (Roma), 2015, Vol.100, p.29

2015

Link zum Volltext

Verfügbarkeit prüfen

P1009: PREDICTORS OF HOSPITALIZATION AND SEVERE OUTCOMES IN PATIENTS WITH MPN AND COVID‐19

HemaSphere, 2022-06, Vol.6 (Suppl), p.899-900

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of In Vivo T-Cell Depletion on Outcome Following Reduced Intensity Transplantation for Hodgkin Lymphoma: Comparison between 2 Prospective Studies

Blood, 2004-11, Vol.104 (11), p.807-807

2004

Link zum Volltext

Verfügbarkeit prüfen

Predicción del riesgo de trombosis y de la supervivencia en la trombocitemia esencial

Medicina clínica, 2015-03, Vol.144 (6), p.257-258

Hernández Boluda, Juan Carlos

2015

Link zum Volltext

Verfügbarkeit prüfen

Reconstitution of CMV pp65 and IE-1-specific IFN- gamma CD8 super(+) and CD4 super(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2011-11, Vol.46 (11), p.1437-1443

2011

Link zum Volltext

Verfügbarkeit prüfen

Reconstitution of CMV pp65 and IE-1-specific IFN-y CD8+ and CD4+ T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2011, Vol.46 (11), p.1437-1443

2011

Link zum Volltext

Verfügbarkeit prüfen

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNg CD8 super(+) and CD4 super(+) T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 2010-03, Vol.45 (3), p.543-549

2010

Link zum Volltext

Verfügbarkeit prüfen

Enumeration of cytomegalovirus-specific interferon CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection

Haematologica (Roma), 2008-09, Vol.93 (9), p.1434-1436

2008

Link zum Volltext

Verfügbarkeit prüfen

Case report: Guillain-Barre syndrome associated with cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation

Transplant infectious disease, 2005-06, Vol.7 (2), p.93-96

2005

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Risk Management Recommendations for Patients with Chronic Myeloid Leukaemia who are Candidates for Ponatinib: Multidisciplinary Delphi Analysis

Annals of hematology & oncology, 2021-05, Vol.8 (7)

2021

Link zum Volltext

Verfügbarkeit prüfen

104PStudy of toxicity of the conventional treatments in myeloproliferative neoplasms, based on the functional status of the RUNX1/CBF-BETA/P300/HIPK2 complex

Annals of oncology, 2018-09, Vol.29 (suppl_6)

2018

Link zum Volltext

Verfügbarkeit prüfen

Reconstitution of CMV pp65 and IE-1-specific IFN-[gamma] CD8+ and CD4+ T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2011-11, Vol.46 (11), p.1437

2011

Link zum Volltext

Verfügbarkeit prüfen

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFN[gamma] CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 2010-03, Vol.45 (3), p.543

2010

Link zum Volltext

Verfügbarkeit prüfen

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 2010-03, Vol.45 (3), p.543-549

2010

Link zum Volltext

Verfügbarkeit prüfen

Early Hepatotoxicity in Patients with Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)

Blood, 2022-11, Vol.140 (Supplement 1), p.7585-7586

2022

Link zum Volltext

Verfügbarkeit prüfen

A Simple Prognostic System in Myelofibrosis Patients Undergoing Allogeneic Stem Cell Transplant: A CIBMTR/EBMT analysis

Blood advances, 2023-05

2023

Link zum Volltext

Verfügbarkeit prüfen

PS1186 CURRENT DOSE RECOMMENDATIONS FOR PONATINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS CAN DIMINISH ADVERSE EVENTS WHILE MAINTAINING EFFICACY

HemaSphere, 2019-06, Vol.3 (S1), p.540-541

2019

Link zum Volltext

Verfügbarkeit prüfen

Reconstitution of CMV pp65 and IE-1-specific IFN-[gamma] [CD8.sup.+] and [CD4.sup.+] T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT.(ORIGINAL ARTICLE)

Bone marrow transplantation (Basingstoke), 2011-11, Vol.46 (11), p.1437

2011

Link zum Volltext

Verfügbarkeit prüfen

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFN[gamma] [CD8.sup.+] and [CD4.sup.+] T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 2010-03, Vol.45 (3), p.543

2010

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

P997: PROTEOMIC ANALYSIS ON PLATELETS OF ESSENTIAL THROMBOCYTHEMIA PATIENTS UNDERSCORES THE ROLE OF MITOCHONDRIA IN JAK2 V617F PLATELET REACTIVITY AND FUNCTION

Study of toxicity of the conventional treatments in myeloproliferative neoplasms, based on the functional status of the RUNX1/CBF-BETA/P300/HIPK2 complex

When should preemptive antiviral therapy for active CMV infection be withdrawn from allogeneic stem cell transplant recipientsquest

Treatment Of Essential Thrombocythemia In Europe: Observational Study Of 3649 Patients Of High Risk (Exels)

P1009: PREDICTORS OF HOSPITALIZATION AND SEVERE OUTCOMES IN PATIENTS WITH MPN AND COVID‐19

Impact of In Vivo T-Cell Depletion on Outcome Following Reduced Intensity Transplantation for Hodgkin Lymphoma: Comparison between 2 Prospective Studies

Predicción del riesgo de trombosis y de la supervivencia en la trombocitemia esencial

Reconstitution of CMV pp65 and IE-1-specific IFN- gamma CD8 super(+) and CD4 super(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT

Reconstitution of CMV pp65 and IE-1-specific IFN-y CD8+ and CD4+ T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNg CD8 super(+) and CD4 super(+) T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

Enumeration of cytomegalovirus-specific interferon CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection

Case report: Guillain-Barre syndrome associated with cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation

Cardiovascular Risk Management Recommendations for Patients with Chronic Myeloid Leukaemia who are Candidates for Ponatinib: Multidisciplinary Delphi Analysis

P1032: REAL‐LIFE VALIDATION OF MIPSS70: A RETROSPECTIVE MULTICENTER AND NGS ANALYSIS FROM THE GEMFIN DATABASE

104PStudy of toxicity of the conventional treatments in myeloproliferative neoplasms, based on the functional status of the RUNX1/CBF-BETA/P300/HIPK2 complex

Reconstitution of CMV pp65 and IE-1-specific IFN-[gamma] CD8+ and CD4+ T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFN[gamma] CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

Early Hepatotoxicity in Patients with Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)

Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in Europe between 1995-2018: An EBMT Retrospective Analysis

A Simple Prognostic System in Myelofibrosis Patients Undergoing Allogeneic Stem Cell Transplant: A CIBMTR/EBMT analysis

PS1186 CURRENT DOSE RECOMMENDATIONS FOR PONATINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS CAN DIMINISH ADVERSE EVENTS WHILE MAINTAINING EFFICACY

Reconstitution of CMV pp65 and IE-1-specific IFN-[gamma] [CD8.sup.+] and [CD4.sup.+] T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT.(ORIGINAL ARTICLE)

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFN[gamma] [CD8.sup.+] and [CD4.sup.+] T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

Aktive Filter

Suchergebnisse filtern